-
Mad Money Lightning Round: Cramer Likes Airgas (TIBX, CBU, FNFG, SWC, ARG)
Wednesday, March 16, 2011 - 2:48am | 178On CNBC's Mad Money, Jim Cramer said during the Lightning Round that TIBCO Software (NASDAQ: TIBX) is a “cloud software play but I'm not overstaying my welcome. Let's take profits." He believes that Community Bank System (NYSE: CBU) is “fine.” He added, “I prefer First Niagara Financial (NASDAQ:...
-
Celamin Holdings NL (ASX:CNL) Update On Companies Projects And Activities
Sunday, March 13, 2011 - 10:35pm | 855Melbourne, Mar 14, 2011 (ABN Newswire) - Celamin Holdings NL (ASX:CNL) is please to update on companies projects and activities. Bir El Afou Phosphate Project 1. Field Activities Celamin's work in the Bir El Afou (BEA) permit area has been significantly expedited by the co-operation and local...
-
Dividend Graveyard: 4 High Yield Stocks That Could Cut Their Dividends This Year
Sunday, March 13, 2011 - 6:14pm | 126By Roger Choudhury, Lead Editor We screened for companies with dividend yields above 5%, and looked for low EBT margins, slowing revenue growth or low returns on capital. We'd identified 4 stocks that could be heading to the dividend graveyard. For our other graveyard picks, see here. Hudson City...
-
Options Brief: Capitol Federal Financial (CFFN)
Friday, March 11, 2011 - 4:06pm | 82Shares of Capitol Federal Financial (NASDAQ: CFFN) are higher on the session by 0.85%, trading at $11.88. Overall put volume is now running at 10.51x the daily average, with 80% of all puts traded being purchases on the offer. 2,060 contracts have traded on the session so far. Capitol Federal...
-
Piper Jaffray Trims Regeneron Pharmaceuticals PT To $48 (REGN)
Friday, March 11, 2011 - 10:10am | 164Piper Jaffray trimmed its Regeneron Pharmaceuticals (NASDAQ: REGN) price target from $49 to $48 and left Regeneron's Overweight rating unchanged in a research report. In the report, Piper Jaffray states, "Aflibercept missed the primary endpoint of overall survival (OS) in the pivotal VITAL trial...
-
Regeneron Pharms Reports Top-Line Phase III Results (REGN)
Thursday, March 10, 2011 - 5:08pm | 431Sanofi-aventis and Regeneron Pharmaceuticals (NASDAQ: REGN) today announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment of non-small cell lung cancer (NSCLC). The data showed that adding aflibercept to the...
-
FBR Capital Downs VPFG To Market Perform
Wednesday, March 9, 2011 - 7:03am | 56Analysts at FBR Capital downgrade ViewPoint Financial Group (NASDAQ: VPFG) from “outperform” to “market perform.” The target price for VPFG is set to $13. VPFG shares gained 0.45% to close at $13.34 yesterday. More Analyst Ratings here
-
Calls Purchased on New York Community Bancorp (NYB)
Tuesday, March 8, 2011 - 3:28pm | 126Shares of New York Community Bancorp (NYSE: NYB) are higher on the session by 0.34%, currently trading at $17.63. The stock has been moving largely lower over the past three months and is currently consolidating between the 50-day and 200-day moving averages. Options traders are buying calls on...
-
Calls Purchased on Hudson City Bancorp (HCBK)
Tuesday, March 8, 2011 - 12:54pm | 146Shares of Hudson City Bancorp (NASDAQ: HCBK) are higher on the session by 2.03%, currently trading at $10.04. The stock has been moving largely lower over the past six months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying calls on the name today...
-
Roma Financial Corporation Reports 2010 EPS of $0.17
Tuesday, March 8, 2011 - 11:31am | 152Roma Financial Corporation (Nasdaq: ROMA) the holding company of Roma Bank and RomAsia Bank, announced today its financial condition and results of operations for the three months and year ended December 31, 2010. The Company's consolidated net income, for the three months and year ended December...
-
Keefe Bruyette & Woods Has Outperform Rating On Viewpoint Financial Group (VPFG)
Tuesday, March 8, 2011 - 8:39am | 106Keefe Bruyette & Woods has an Outperform rating and a $15.50 price target on shares of Viewpoint Financial Group (NASDAQ: VPFG). In a note to investors, KBW writes, "Overall a good quarter due to margin expansion, PTPP ROA improvement, stable asset quality and strong capital levels. Loan...
-
Piper Jaffray Reiterates OW Rating On OCN
Monday, March 7, 2011 - 9:17am | 136Piper Jaffray is reiterating its Overweight rating on Ocwen Financial Corp. (NYSE: OCN) following recent travel with management. “OCN has a number of value-creating initiatives (servicing rights acquisitions, FHA flow servicing, FNM/FRE servicing) on the horizon that could significantly boost...
-
KBW Reiterates $13 PT, Market Perform Rating On HOME
Monday, March 7, 2011 - 8:33am | 36KBW is reiterating its $13 PT and Market Perform rating on shares of Home Federal Bancorp Inc. (NASDAQ: HOME). Federal Bancorp Inc. closed Friday at $10.95.
-
UPDATE: KBW Color On FDEF Rating Change, PT Increase
Monday, March 7, 2011 - 8:30am | 112KBW, which raised its PT and rating on shares of First Defiance Financial Corp. (NASDAQ: FDEF), is providing some color on the stock. “We are transferring coverage of First Defiance to John Barber from Eileen Rooney,” KBW writes. “We are also adjusting our earnings estimates. “Given that FDEF...
-
Keefe Bruyette Ups FDEF To Outperform
Monday, March 7, 2011 - 6:49am | 57Analysts at Keefe Bruyette upgrade First Defiance Financial (NASDAQ: FDEF) from “market perform” to “outperform.” The target price for FDEF is set to $17. FDEF shares fell 0.14% to close at $14.00 on Friday. More Analyst Ratings here